Blog

Nos complace anunciar el lanzamiento oficial de la versión 2.0 de nuestro software Adellgene® Triplet Repeat Calculator, una herramienta muy útil para la interpretación de resultados obtenidos con nuestros kits Adellgene®. 

Nos complace anunciar el lanzamiento oficial de la versión 2.0 de nuestro software Adellgene® Triplet Repeat Calculator, una herramienta muy útil para la interpretación de resultados obtenidos con nuestros kits Adellgene®. 

Nos complace anunciar el lanzamiento oficial de la versión 2.0 de nuestro software Adellgene® Triplet Repeat Calculator, una herramienta muy útil para la interpretación de resultados obtenidos con nuestros kits Adellgene®. 

Nos complace anunciar que nuestro distribuidor en Colombia, la empresa Annar Healthcare, ha creado un video en el que el Dr. Daniel Salgado brinda una visión general completa de la tecnología de análisis de fragmentos y su importancia en el diagnóstico de trastornos de expansión trinucleótida como la enfermedad de

Blackhills Diagnostic Resources S.L.U. participa en el Programa «PAIP», cuyo resultado es favorecer el crecimiento y consolidación de la PYME, mejorando su financiación, tecnología y el acceso a servicios de apoyo avanzados. El objetivo fundamental es conseguir un tejido empresarial más competitivo.

On Monday 12 September, Carolina Orrite, Field Application Specialist at BDR, participated in the 2nd Cycle of Experts in Human Molecular Genetics organised by our distributor Annar Health Technologies. The session, which took place online, covered several points. It began with an introduction to BDR, explaining the Genvinset® and Adellgene®

Image obtained from the website https://www.iislafe.es/ Huntington’s disease (HD) is an inherited, degenerative disease caused by an expansion of the CAG triplet (cytosine, adenine and guanine) in the first exon of the HTT gene encoding the huntingtin protein. When these expansions are repeated 36 times or more, patients suffer neurodegeneration. This

There are only 3 weeks left until the implementation of the new European Regulation on In Vitro Diagnostic Medical Devices, which aims to create a safer, more transparent, reliable and predictable environment for these products.  For us as manufacturers, this new regulation is good news as, for the first time, the requirements

Yesterday, the 14th of November, was the World Diabetes Day, celebrated on the day of the birthday of Sir Frederick Banting, who co-discovered insulin along with Charles Best in 1922. This day has been commemorated since 1991, in response to growing concerns about the escalating health threat posed by diabetes.

July is Fragile X Syndrome Awareness Month! In addition, yesterday we celebrated the Fragile X Awareness Day, and for this reason, we would like to share with you a Q&A section that we have prepared about our Fragile X Syndrome Kits of the Adellgene product line. Here are some of